United States · FDA National Drug Code directory
Gabapentin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81033-123_4470a571-3213-9849-e063-6394a90a39b2
- Product NDC
- 81033-123
- Form
- SOLUTION
- Composition / generic term
- Gabapentin
- Labeler
- Kesin Pharma Corporation
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250806
- Source listing expiry
- 20261231
Source-listed ingredients
- GABAPENTIN — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 473 mL in 1 BOTTLE (81033-123-16) · 81033-123-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →